A Review of the Totality of Evidence Supporting the Development of the First Adalimumab Biosimilar ABP 501
Material type:
TextSubject(s): Online resources:
| Item type | Current library | Call number | URL | Status | Date due | Barcode |
|---|---|---|---|---|---|---|
eBooks
|
Link to resource | Available |
eBooks
There are no comments on this title.